SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $1.08M invested in Salarius Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$48.5K
2
+$40.5K

Top Sellers

1
-$144K
2
-$52K
3
-$39K
4
BlackRock
BlackRock
New York
-$22K
5
TSS
Two Sigma Securities
New York
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$769K
2
$97K
3
$78K
4
$66K
5
$26K
6
$16K
7
$12K
8
$11K
9
$7K
10
$2K
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–